Anti-Membrane Protein Antibody Services

Between 20% and 30% of the genes in a genome encode membrane proteins, and these proteins take part in nearly every cellular activity — ligand–receptor binding, signal transduction, molecular transport, cell–cell recognition, and enzyme catalysis. Because they sit at so many decision points in cell biology, membrane proteins are among the most important targets in drug discovery and clinical research, and antibodies that act on them are correspondingly valuable as research reagents.

Raising those antibodies, however, is not a routine exercise. Preparing an antibody against a membrane protein runs into low expression, difficult extraction and purification, problems that arise when the gene is expressed in a foreign host, misfolding, incomplete post-translational modification, and conformational differences from the native protein. A purified recombinant fragment often presents an epitope that does not exist on the protein as it appears in a cell. Our anti-membrane protein services are built to avoid that mismatch: the target is presented in a membrane environment so the antibody is selected against the native structure rather than an isolated fragment.

Why Membrane Protein Antibodies Need a Dedicated Approach

• Expression is limiting – many membrane proteins are produced at low levels, and overproduction disrupts the host cell, so antigen supply has to be engineered deliberately.
• Conformation carries the epitope – isolating a soluble fragment can destroy the structure the antibody must recognize.
• Purification is difficult – extracting a functional membrane protein without denaturing it is a project in itself.
• Presentation determines specificity – how the antigen is displayed to the immune system decides whether the resulting antibody is useful.

Service Areas

Which Service Fits Your Target

How a Membrane Protein Project Runs

• Assess the target – define the membrane protein, its topology, and the property that makes it difficult.
• Choose the presentation route – whole-cell display, hybridoma preparation, or a target-class-specific route.
• Produce the antigen – generate the membrane protein in a form that keeps the relevant conformation.
• Screen and validate – select candidates against the native target and confirm behavior in the intended application.

How We Support Your Program

• Multiple presentation platforms – cell membrane, phospholipid protein membrane, and liposome environments applied as the target requires.
• Antigen supply – expression and purification routes that address low yield and instability.
• Documented evidence – screening and validation data that travel with the antibody.
• Continuity across targets – move between membrane protein families within one program without changing suppliers.

An Integrated Approach

Because the routes share a single principle — present the membrane protein close to its native state, then screen against that state — a program that touches several classes of membrane protein can be managed as one continuous effort rather than a set of unrelated attempts. Whether the target is a receptor, a channel, or a structurally simpler membrane protein, the same reasoning about conformation and presentation guides the choice of route, keeping the work coherent from first antigen design to final validation.